Merck trades lower after 1Q results – The trend remains bullish
Nicolas Suiffet May 14, 2020 5:28 PM
Merck KGaA, the chemicals and pharmaceuticals group, posted 1Q net income surged to 458 million euros from 190 million euros in the prior-year period
Merck KGaA, the chemicals and pharmaceuticals group, posted 1Q net income surged to 458 million euros from 190 million euros in the prior-year period and adjusted EBITDA rose 27.2% on year to 1.18 billion euros on revenue of 4.37 billion euros, up 16.7%. Regarding full-year outlook, the company said: "Group EBITDA pre is expected to be in a range of between E4.35 billion and E4.85 billion. Owing to strong restrictions of economic life and declining income in the context of the Covid-19 pandemic with correspondingly adverse effects on the businesses, Merck forecasts a merely stable organic development."
From a technical perspective, the bearish gap opened this morning calls for a short term consolidation move. However, the trend remains bullish. A pennant pattern is taking shape. (Continuation trend pattern). The daily Relative Strength Index (RSI, 14) is above 50% and is not overbought (<70%).
As long as 95E is support, the bias is bullish. The validation of the pennant pattern would call for a new rise towards 110E and 118.4E.
Alternatively, a break below 95E would negate the bullish view and would call for a reversal down trend with 87.45E as first target.
Source: GAIN Capital, TradingView
From time to time, GAIN Capital Australia Pty Ltd (“we”, “our”) website may contain links to other sites and/or resources provided by third parties. These links and/or resources are provided for your information only and we have no control over the contents of those materials, and in no way endorse their content. Any analysis, opinion, commentary or research-based material on our website is for information and educational purposes only and is not, in any circumstances, intended to be an offer, recommendation or solicitation to buy or sell. You should always seek independent advice as to your suitability to speculate in any related markets and your ability to assume the associated risks, if you are at all unsure. No representation or warranty is made, express or implied, that the materials on our website are complete or accurate. We are not under any obligation to update any such material.
As such, we (and/or our associated companies) will not be responsible or liable for any loss or damage incurred by you or any third party arising out of, or in connection with, any use of the information on our website (other than with regards to any duty or liability that we are unable to limit or exclude by law or under the applicable regulatory system) and any such liability is hereby expressly disclaimed.